GHUCCTS

News

Share This
  • Oct 22, 2020

TIN convalescent plasma study by former GHUCCTS KL2 scholar Dr. Seble Kassaye featured on NBC4

Dr. Seble Kassaye, infectious disease expert at Georgetown University Medical Center and former GHUCCTS KL2 scholar, is the principal investigator for a local convalescent plasma COVID-19 clinical trial. Dr. Kassaye recently appeared on NBC4 Washington to discuss the trial.

This trial is led by Johns Hopkins University. MedStar Georgetown University HospitalMedStar Washington Hospital Center, and Georgetown University Medical Center are serving as subsites for the trial, with support from GHUCCTS and the Trial Innovation Network (TIN). This study is for people at high risk of exposure to COVID-19, such as hospital personnel (clinical staff, environmental services, dining services, etc) or anyone who is caring for someone with COVID-19. This study will test whether an infusion of plasma containing antibodies from persons who have recovered from COVID-19 can prevent others from getting it.

Please visit www.covidplasmatrial.org/ or call 888-506-1199 for more information. 

Promotional flyer for Dr. Kassaye's COVID-19 plasma trial. Visit covidplasmatrial.org for more details.

Related News

GHUCCTS announces 2020 KL2 Scholar Dr. Haiyan He

Nov 13, 2020

After our 10th highly competitive application cycle, unfortunately delayed due to COVID-related research closures, the Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is pleased to announce the appointment of Dr. Haiyan He as a KL2 Scholar. This new awardee, her research project, and training plan are emblematic of our program objectives in that they pair a highly-promising scholar-trainee with a mentor team that includes senior colleagues from across disciplines, departments, campuses, and institutions to pursue research that depends upon collaborations and methods from outside the scholars’ discipline, local research environment, or past experiences.

Application open for 2021 KL2 Scholars Program

Nov 13, 2020

The Georgetown-Howard Universities Center for Clinical and Translational Science (GHUCCTS) is now accepting applications for our 2021 KL2 Scholars Program. The pre-application is due December 31, 2020 with the final application due February 1, 2021. Funding is expected to begin in June 2021 pending the evolution of the COVID-19 pandemic.

ACTS now accepting session proposals and abstracts for TS21

Nov 01, 2020

The Association for Clinical and Translational Science (ACTS) is now accepting session proposals and abstracts for Translational Science 2021.

Close